2007
DOI: 10.1001/archderm.143.12.1597
|View full text |Cite
|
Sign up to set email alerts
|

Clinical Improvement of Pityriasis Rubra Pilaris With Combination Etanercept and Acitretin Therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0
2

Year Published

2008
2008
2021
2021

Publication Types

Select...
4
3
2

Relationship

0
9

Authors

Journals

citations
Cited by 33 publications
(19 citation statements)
references
References 6 publications
0
17
0
2
Order By: Relevance
“…Infliximab monotherapy proved equally effective in one adult‐onset type I PRP patient and in one patient of classic type III juvenile PRP 12 . Etanercept monotherapy or in combination with steroids was successfully used in two cases of type I PRP, resistant to traditional therapy 9,13 . Lack of efficacy of infliximab and acitretin combination therapy was reported by Lu et al.…”
Section: Discussionmentioning
confidence: 88%
“…Infliximab monotherapy proved equally effective in one adult‐onset type I PRP patient and in one patient of classic type III juvenile PRP 12 . Etanercept monotherapy or in combination with steroids was successfully used in two cases of type I PRP, resistant to traditional therapy 9,13 . Lack of efficacy of infliximab and acitretin combination therapy was reported by Lu et al.…”
Section: Discussionmentioning
confidence: 88%
“…Of note, the first case of type III classic juvenile-onset PRP successfully treated with infliximab has recently been reported, 12 and the first two cases of type I PRP treated successfully with combination etanercept and acitretin therapy have emerged. 13,14 The T cell modulator efalizumab has been suggested to improve the disease in a 10-year-old boy unresponsible to multiple common therapies 15 but to exacerbate it in an adult patient. 16 In summary, the above listed cases with TNF-a inhibitors propose a significant response to anti-TNF-a therapy when used in combination therapy and/or in pretreated patients.…”
Section: Discussionmentioning
confidence: 99%
“…To date, a total of 16 patients with PRP who were treated with etanercept have been reported. These patients were treated with a dose of 25–50 mg twice per week, and at least seven of them had a combined therapy of etanercept and acitretin, methotrexate and UVA1 . However, two of the four patients described by Garcovich et al .…”
Section: Treatment With Biologics and Small Moleculesmentioning
confidence: 99%